Xenpozyme: a revelation for Neiman-Pick disease

Authors

  • Ariyan Khan Deccan College of Medical Sciences, Hyderabad, Telangana, India
  • Khaja Kamaluddin Khan Deccan College of Medical Sciences, Hyderabad, Telangana, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20232067

Keywords:

Xenpozyme, Neiman-Pick disease, Acid sphingomyelinase deficiency

Abstract

Nieman-Pick disease (NPD) also known as acid sphingomyelinase deficiency (ASMD) is a rare autosomal recessive disorder of lysosomal storage which affects 1 in 250,000 individuals mainly belonging to the Ashkenazi Jew population. The prevalence varies across the three main subtypes where type A and B affects 1 in 40,000 and type C affects 1 in 150,000 individuals, being more prevalent in the French-Acadian descent in the region of Nova Scotia.

Metrics

Metrics Loading ...

References

Bianconi SE, Hammond DI, Farhat NY, Dang Do A, Jenkins K, Cougnoux A, et al. Evaluation of Age of Death in Niemann-Pick Disease, type C: Utility of Disease Support Group Websites to Understand Natural History. Mol Genet Metab. 2019;126(4):466-9.

Thurm A, Chlebowski C, Joseph L, Farmer C, Adedipe D, Weiss M, et al. Neurodevelopmental Characterization of Young Children Diagnosed with Niemann-Pick Disease, Type c1. J Dev Behav Pediatr. 2020;41(5):388-96.

Nafeesuddin MM, Mustafa MS, Mussarat A, Azam ST, Siddiq MA. Xenpozyme: The First Spellbound Therapy. IJS Global Health. 2023;6(2):e122.

Bajwa H, Azhar W. Niemann-Pick Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.

Santos-Lozano A, Villamandos García D, Sanchis-Gomar F, Fiuza-Luces C, Pareja-Galeano H, Garatachea N, et al. Niemann-Pick Disease Treatment: A Systematic Review of Clinical Trials. Ann Transl Med. 2015;3(22):360.

Wasserstein M, Lachmann R, Hollak C, Arash-Kaps L, Barbato A, Gallagher RC, et al. A randomized, Placebo-Controlled Clinical Trial Evaluating Olipudase Alfa Enzyme Replacement Therapy For Chronic Acid Sphingomyelinase Deficiency (ASMD) in Adults: One-year Results. Genet Med. 2022;24(7):1425-36.

Diaz GA, Jones SA, Scarpa M, Mengel KE, Giugliani R, Guffon N, et al. One-year Results of A Clinical Trial of Olipudase Alfa Enzyme Replacement Therapy in Pediatric Patients with Acid Sphingomyelinase Deficiency. Genet Med. 2021;23(8):1543-50.

Downloads

Published

2023-06-29

How to Cite

Khan, A., & Kamaluddin Khan, K. (2023). Xenpozyme: a revelation for Neiman-Pick disease. International Journal Of Community Medicine And Public Health, 10(7), 2652–2653. https://doi.org/10.18203/2394-6040.ijcmph20232067

Issue

Section

Letter to the Editor